AC Immune S.A.
ACIU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $36 | $78 | $32 | $82 |
| Short-Term Investments | $129 | $25 | $91 | $116 |
| Receivables | $1 | $15 | $0 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $7 | $5 | $3 |
| Total Curr. Assets | $172 | $125 | $128 | $203 |
| Property Plant & Equip (Net) | $8 | $7 | $7 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $50 | $50 | $50 | $50 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $59 | $58 | $58 | $59 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $231 | $183 | $186 | $261 |
| Liabilities | – | – | – | – |
| Payables | $3 | $2 | $1 | $2 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $97 | $11 | $10 | $17 |
| Total Curr. Liab. | $101 | $14 | $11 | $20 |
| LT Debt | $4 | $3 | $2 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $13 | $6 | $3 | $7 |
| Total NC Liab. | $18 | $9 | $5 | $9 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $3 | $3 | $3 |
| Total Liabilities | $119 | $22 | $17 | $29 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2 | $2 | $2 | $2 |
| Retained Earnings | -$368 | -$316 | -$264 | -$201 |
| AOCI | -$0 | -$0 | $0 | $0 |
| Other Equity | $478 | $475 | $431 | $431 |
| Total Equity | $112 | $161 | $169 | $232 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $231 | $183 | $186 | $261 |
| Net Debt | -$31 | -$75 | -$29 | -$79 |